214 related articles for article (PubMed ID: 8751826)
1. Isolation of opportunistic fungi from bronchoalveolar lavage of compromised hosts in Isfahan, Iran.
Shadzi S; Chadeganipour M
Mycopathologia; 1996; 133(2):79-83. PubMed ID: 8751826
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenic fungi with increasing proliferation].
Dynowska M; Biedunkiewicz A
Wiad Parazytol; 2001; 47(4):609-13. PubMed ID: 16886398
[TBL] [Abstract][Full Text] [Related]
3. The incidence of opportunistic fungi in patients suspected of tuberculosis.
Chadeganipour M; Shadzi S; Dehghan P; Bijary J
Mycoses; 2000 Sep; 43(7-8):269-72. PubMed ID: 11036396
[TBL] [Abstract][Full Text] [Related]
4. Emerging fungal pathogens.
Anaissie EJ; Bodey GP; Rinaldi MG
Eur J Clin Microbiol Infect Dis; 1989 Apr; 8(4):323-30. PubMed ID: 2497012
[TBL] [Abstract][Full Text] [Related]
5. Cytopathology of opportunistic infection in bronchoalveolar lavage.
Linder J; Vaughan WP; Armitage JO; Ghafouri MA; Hurkman D; Mroczek EC; Miller NG; Rennard SI
Am J Clin Pathol; 1987 Oct; 88(4):421-8. PubMed ID: 2821792
[TBL] [Abstract][Full Text] [Related]
6. Changing epidemiology of systemic fungal infections.
Richardson M; Lass-Flörl C
Clin Microbiol Infect; 2008 May; 14 Suppl 4():5-24. PubMed ID: 18430126
[TBL] [Abstract][Full Text] [Related]
7. Emerging opportunistic yeast infections.
Miceli MH; Díaz JA; Lee SA
Lancet Infect Dis; 2011 Feb; 11(2):142-51. PubMed ID: 21272794
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of the effect of constructions in hospital environment on the crucial units for immunocompromised patients and the development of opportunistic mold infections].
Eren A; Kuştimur S; Kalkanci A; Unverdi S; Aktaş F; Sucak GT
Mikrobiyol Bul; 2008 Jan; 42(1):83-93. PubMed ID: 18444565
[TBL] [Abstract][Full Text] [Related]
9. Overview of systemic fungal infections.
Rolston K
Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):11-4. PubMed ID: 11757845
[TBL] [Abstract][Full Text] [Related]
10. [Agents of otomycosis in Manisa region, Turkey, 1995-2011].
Değerli K; Ecemiş T; Günhan K; Başkesen T; Kal E
Mikrobiyol Bul; 2012 Jan; 46(1):79-84. PubMed ID: 22399174
[TBL] [Abstract][Full Text] [Related]
11. [Invasive fungal disease in patients from five hospitals in the Valparaíso region, Chile: 2004 to 2009].
Cruz Ch R; Piontelli L E
Rev Chilena Infectol; 2011 Apr; 28(2):123-9. PubMed ID: 21720691
[TBL] [Abstract][Full Text] [Related]
12. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.
Pfaller MA; Diekema DJ
J Clin Microbiol; 2004 Oct; 42(10):4419-31. PubMed ID: 15472288
[No Abstract] [Full Text] [Related]
13. [An epidemiological study for fungus isolation during the twenty-five year periods from 1976 to 2000 in Kitasato University Hospital].
Obata S; Hirata Y; Sunakawa K; Inoue M
Kansenshogaku Zasshi; 2001 Oct; 75(10):863-9. PubMed ID: 11712361
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of invasive mycoses in North America.
Pfaller MA; Diekema DJ
Crit Rev Microbiol; 2010; 36(1):1-53. PubMed ID: 20088682
[TBL] [Abstract][Full Text] [Related]
15. [Fungi isolated from the stool in patients with gastrointestinal disorders in 2005 - 2009].
Macura AB; Witalis J
Przegl Epidemiol; 2010; 64(2):313-7. PubMed ID: 20731244
[TBL] [Abstract][Full Text] [Related]
16. Uncommon opportunistic fungi: new nosocomial threats.
Groll AH; Walsh TJ
Clin Microbiol Infect; 2001; 7 Suppl 2():8-24. PubMed ID: 11525222
[TBL] [Abstract][Full Text] [Related]
17. [Identification of filamentous fungi isolated from clinical samples by two different methods and their susceptibility results].
Direkel S; Otağ F; Aslan G; Ulger M; Emekdaş G
Mikrobiyol Bul; 2012 Jan; 46(1):65-78. PubMed ID: 22399173
[TBL] [Abstract][Full Text] [Related]
18. Growing importance of non-Candida species as opportunistic pathogens.
Tomsíková A
Cent Eur J Public Health; 1998 Feb; 6(1):61-6. PubMed ID: 9524745
[TBL] [Abstract][Full Text] [Related]
19. DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses.
Campa D; Tavanti A; Gemignani F; Mogavero CS; Bellini I; Bottari F; Barale R; Landi S; Senesi S
J Clin Microbiol; 2008 Mar; 46(3):909-15. PubMed ID: 18160452
[TBL] [Abstract][Full Text] [Related]
20. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
